News
StockStory.org on MSN3d
10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings?Genomics has been treading water for the past six months, holding steady at $14.80. The stock also fell short of the S&P ...
In a landmark deal shaking the North American mining sector, mid-tier gold producer Torex Gold Resources Inc. (TSX: TXG) ...
Torex Gold Resources (TSX: TXG) is doubling down on Mexico, sealing a C$449 million ($327 million) all-share deal to acquire ...
Torex Gold (TSX: TXG) appears to be on a bit of a buying spree, with the company this morning announcing that it has reached ...
The deal increases Torex's gold resources by 32% to 6.2M ounces and diversifies its portfolio with more silver exposure.
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases ...
You’ve reached your limit of free weekly articles Keep reading The Northern Miner with a TNM NEWS+MARKETS Membership. TNM Memberships is your key to unlocking access to the best ...
Detailed price information for Torex Gold Resources Inc (TXG-T) from The Globe and Mail including charting and trades.
Detailed price information for Torex Gold Resources Inc (TORXF) from The Globe and Mail including charting and trades.
10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Despite a challenging macro environment, 10x Genomics Inc (TXG) showcases resilience with strong consumables growth and strategic cost-saving measures.
I assign TXG a buy rating with a 1-year price target of $12.7 per share, projecting an 18% upside YoY. TXG's new lower-cost Chromium offerings could drive volume growth and increased adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results